Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Source: 
BioSpace
snippet: 
  • Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
  • Transaction includes worldwide exclusive rights for development and commercialization in all fields of use